Legal Alliance Company is pleased to inform you of new services, that we have developed for pharmaceutical companies running business in Ukraine.
Due to the growing competition among the participants of the pharmaceutical market (competitive cases, public procurement, etc.), the winner is the one who is aware beforehand of the risks that threaten its products being circulated in the market. Accordingly, it is possible to take preventive actions related to the legal protection of your products from competitorsat pre-registration and registration stages.
According to our practice, the state registration of medicines is frequently completed without conducting a comprehensive patent search. Hence, upon the registration in Ukraine themanufacturer company will be engaged in a dispute. It is not a secret that it is much cheaper to eliminate competitor's product from the market by means of cancellation of its registration within the court procedure , than to invest in the promotional activity of the medicine with a purpose of leaving behind a direct competitor. On the other hand, as a rule, the difference in price between the generic and the original version of the product is so significant that money losses due to correction of the price to the original drug is ten times greater than the expenses for the court proceedings. As an example of similar situations may serve well-known cases for the protection of products containing escitalopram, ritonavir, abacavir, perindopril and others.
In order to ensure stability and success of medicinal product at its market segment, we would recommend to take care of it reliable legal backup being provided with the following legal services:
Should you be interested in a more detailed proposal, please contact a Partner with Legal Alliance Company Ilya Kostin (kostin@l-a.com.ua) by e-mail or phone +38 044 220 15 84(85, 86).
28 April 2012
Lidiya Sangarovskaya-Gurlach spoke at the XIV International Conference "Age aspects of neuroscience"
19 April 2012
12 April 2012
Legal Alliance advises large pharmaceutical manufacturer on the registration of medicines
12 April 2012